Oncology

@onc_ce on Twitter

Disclosures

Faculty                                  Relationship Identified With:
Dr. Vijaya Raj BhattSafety Monitoring Committee: Protagonist; Consultant: Imugene, Incyte, Abbvie, Genentech, Servier Pharmaceuticals; Institutional research support: Abbvie, Pfizer, Incyte, Jazz, and
National Marrow Donor Program; Drug support (institutional) for a trial: Chimerix
Hossein Borghaei, DO, MSConsultant/Advisor: Amgen; AstraZeneca; Axiom; Beigene; BioNTech; BMS; Boehringer Ingelheim; Daiichi; Da Volterra; EMD-Serono; Genentech; Genmab; Guardant; iTEO; Janssen; Jazz; Kriya; Lilly; Merck; Mirati; Natera; Novartis; Oncocyte; Pfizer; PharmaMar; Regeneron; Takeda: Grant/Research Support: BMS/Lilly; Merck/Celgene; Millennium; Stock Options: Nucleai; Sonnetbio; Rgenix
Harold BursteinNothing to disclose
Dr. Aakash DesaiNothing to disclose
Beth Faiman PhD, MSN, SPRN-BC, AOCN, FAANConsultant: Jannssen, Celgene/BMS, Sanofi Genzyme, Karyopharm
Narjust Florez, MDConsultant/advisory board: BMS, AstraZeneca, DSI, Janssen, Pfizer, Neogenomics, Regeneron
Nicolas Girard MD, PhDConsultant/Research Funding to Institute: Roche, AstraZeneca, Amgen; Research Funding to Institute: PharmaMar
Erika Hamilton, MD
RESEARCH FUNDING – ALL PAYMENTS TO INSTITUTION: Abbvie, Acerta Pharma, ADC Therapeutics, AKESOBIO, Australia, Amgen, Aravive, ArQule, Arvinas, AstraZeneca, AtlasMedx, Black Diamond, Boehringer, Ingelheim, Clovis, Compugen, Curis, CytomX, Daiichi Sankyo, Dana Farber Cancer Inst, Deciphera, eFFECTOR Therapeutics, Ellipses Pharma, EMD Serono, Fochon, FujiFilm, G1, Therapeutics, H3 Biomedicin, Harpoon, Hutchinson MediPharma, Immunogen, Immunomedics, Incyte, InvestisBio, Jacobio, Karyopharm, Leap Therapeutics, Lilly, Lycera, Mabspace, Biosciences, Macrogenics, MedImmune, Merck, Mersana, Merus, Millennium, Molecular, Templates, Myraid Genetic Laboratories, Novartis, Nucana, Olema, OncoMed, Onconova, Therapeutics, ORIC Pharmaceuticals, Orinove, Pfizer, PharmaMar, Pieris Pharmaceuticals , Pionyr Immunotherapeutics, Plexxikon, Radius Health, Regeneron, Repertoire Immune Medicine, Rgenix, Roche/Genentech, Seattle Genetics, Sermonix Pharmaceuticals, Shattuck, Labs, Silverback, StemCentRx, Sutro, Syndax, Syros, Taiho, TapImmune, Tesaro, Treadwell Therapeutics, Verastem, Vincerx Pharma, Zenith Epigenetics, Zymeworks
CONSULTING/ADVISORY ROLE – ALL PAYMENTS TO INSTITUTION: Arcus, Arvinas, AstraZeneca, Black Diamond, Boehringer Ingelheim, CytomX, Daiichi Sankyo, Dantari, Deciphera Pharmaceuticals, Eisai, H3 Biomedicine, iTeos, Janssen, Lilly, Loxo, Merck, Mersana, Novartis, Pfizer, Puma Biotechnology, Relay Therapeutics, Roche/Genentech, Seattle Genetics, Silverback Therapeutics
Suneel Kamath, MDAdvisor: Exelixis; Consultant: Tempus, Guardant
Dr. Pashtoon Kasi, MD, MSConsultant/Advisory Board: Ipsen (institution), Natera, Foundation Medicine, AstraZeneca, MSD Oncology/Merck, Tempus, Bayer, Lilly, Delcath Systems, Axiom Healthcare Strategies, IPBA, QED Therepeutics, Boston Healthcare Associates, Servier, Exact Sciences; Research/Grant Funding: BTG/Boston Scientific (institution), Tesera (institution), AAA/Novartis; Travel/Grant Funding to Present IIT at Conference: AstraZeneca
Alok A. KhoranaHonoraria for Consulting: Janssen, Bayer, Sanofi, Pfizer, Anthos, BMS
Dr. C. Ola LandgrenConsultant: Amgen, Janssen, Pfizer, BMS, GSK, Karyopharm, Oncopeptides; Speaker: Sanofi
Thomas W. LeBlanc, MD, MA, MHS, FAAHPM, FASCOConsultant: AbbVie, Agios/Servier, Astellas, AstraZeneca, BlueNote, BMS/Celgene, CareVive, Flatiron, Genentech, GSK, Novartis, and Pfizer; Advisory Board: AbbVie/Genentech, Agios, and BMS; Honoraria for Speaking: AbbVie, Agios, Astellas, BMS/Celgene, and Incyte; Research funding paid to institution: American Cancer Society, AstraZeneca, BMS, CareVive, Deverra
Therapeutics, Duke University, Jazz Pharmaceuticals, the National Institute of Nursing Research/ National Institutes of Health, and Seattle Genetics; Research contracts pending: GSK and Janssen; Reimbursed for travel: AbbVie, Agios/Servier, BMS/Celgene, and Incyte
Natasha Leighl, MD, MMScConsultant/Advisor: Bayer; GSK; Puma Biotechnology; Grant/Research Support: Amgen; Array; AstraZeneca; Bayer; BMS; Eli Lilly; EMD Serono; Guardant Health; Inivata; Janssen; MSD; Novartis; Pfizer; Roche; Takeda
Dr. Suzanne LentzschEquity Ownership: Caelum Biosciences, Mesoblast, Poseida; Advisory/ Consultant: Caelum Bioscience; Research Grant: Karyopharm, Sanofi; Consultant: Sorrento, Janssen, Celularity, Amgen, Takeda, Gsk, CCO, Oncopeptides
Joseph Mikhael M.D.Consultant: Amgen, BMS, Janssen, Karyopharm, Sanofi, Takeda
Martina Murphy, MDNothing to disclose
Antonio Passaro MD, PhDConsulting or Advisory Role: Roche/Genentech, Bristol Myers Squibb, AstraZeneca, MSD Oncology, Pfizer, Boehringer Ingelheim, Johnson & Johnson/Janssen, Novartis, Lilly
Speakers’ Bureau: AstraZeneca, Johnson & Johnson/Janssen, Boehringer Ingelheim
Sandip P Patel, MDScientific Advisory: Amgen, AstraZeneca, Bristol-Myers Squibb, Certis, Eli Lilly, Jazz, Genentech, Illumina , Merck, Pfizer, Rakuten, Tempus; Research Funding: Amgen, AstraZeneca/MedImmune, Bristol-Myers Squibb, Eli Lilly,  Fate Therapeutics, Gilead, Iovance, Merck, Pfizer, Roche/Genentech, SQZ Biotechnologies
Shruti Rajesh Patel, MDNothing to disclose
Solange Peters, MD, PhDConsultant/Advisor: AbbVie, AiCME, Amgen, Arcus, AstraZeneca, Bayer, Beigene, Biocartis,
BioInvent, Blueprint Medicines, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis, Daiichi
Sankyo, Debiopharm, ecancer, Eli Lilly, Elsevier, F-Star, Fishawack, Foundation Medicine,
Genzyme, Gilead, GSK, Illumina, Imedex, IQVIA, Incyte, Ipsen, iTeos, Janssen, Medscape,
Medtoday, Merck Sharp and Dohme, Merck Serono, Merrimack, Novartis, Novocure,
OncologyEducation, Pharma Mar, Phosplatin Therapeutics, PER, Peerview, Pfizer, PRIME,
Regeneron, RMEI, Roche/Genentech, RTP, Sanofi, Seattle Genetics, Takeda, Vaccibody Grants/Research Support: Principal investigator in trials (institutional financial support for
clinical trials) sponsored by Amgen, AstraZeneca, Beigene, Bristol-Myers Squibb, GSK, Merck
Sharp and Dohme, Roche/Genentech; Speakers Bureau: AiCME, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, ecancer, Eli Lilly, Foundation Medicine, GSK, Illumina, Imedex, Ipsen, Medscape, Merck Sharp and Dohme, Mirati, Novartis, PER, Peerview, Pfizer, Prime, Roche/Genentech, RTP, Sanofi, Takeda
David Planchard. MD, PhDConsultant/Advisor: Abbvie; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Janssen;
Novartis; Pfizer
Dr. Dale ShepardConsultant: Sanofi SA; Research support: Deciphera Pharmaceuticals, Pionyr Immunotherapeutics, Inhibrix, Conjupro Biotherapeutics, Ram Therapeutics, Shanghai Micropeutics, Astellas
Dr. Ann Meredith Garcia TrinidadAdvisory Board: Amgen, Eli Lilly; Speaker: AstraZeneca, Boehringer Ingelheim, MSD, Roche; Writer: Pfizer; Consultant: Sandoz

All relevant financial relationships with ineligible companies for this educational content have been mitigated.